IP Library Patent Application 12302572
Patent Application
App. No. 12/302,572

PROCESS FOR MAKING N-HYDROXY-3-[4-[[[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE AND STARTING MATERIALS THEREFOR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/302,572
Abstract

N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor are prepared by new synthetic methods.

Claims (134)

1 . A method of making N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising the steps of:

(a) combining sodium hydroxide and (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt to form an admixture at a temperature of less than about −15° C.; and subsequently

(b) adding hydroxylamine to the admixture to form the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

2 . The method of claim 1 , wherein the temperature in step (a) is less than about −10° C.

3 . The method of claim 1 , wherein the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt is provided in the form of a suspension in methanol.

4 . The method of claim 1 , wherein the sodium hydroxide is provided in the form of a solution in methanol.

5 . The method of claim 1 , wherein the sodium hydroxide is added to the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt over about 30 minutes.

6 . The method of claim 1 , wherein the sodium hydroxide is used in an amount ranging from about 2.5 to about 3.5 equivalents.

7 . The method of claim 1 , wherein the hydroxylamine is supplied in the form of a solution in water.

8 . The method of claim 1 , wherein the hydroxylamine is used in an amount ranging from about 4 to about 13 equivalents.

9 . The method of claim 1 , wherein the hydroxylamine is added to the admixture over about 30 minutes.

10 . The method of claim 1 further comprising the step of stirring at the temperature of step (a) until the reaction is complete or nearly complete.

11 . The method of claim 1 further comprising step (c) crystallizing the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

12 . The method of claim 11 , wherein step (c) comprises the sub-steps of:

(c1) heating the reaction mixture formed in step (b);

(c2) stirring the reaction mixture;

(c3) adding water to the reaction mixture;

(c4) filtering the reaction mixture to provide a filtrate;

(c5) adjusting the pH of the filtrate to a pH ranging from about 10 to about 11;

(c6) adding seed crystals of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide to the filtrate;

(c7) stirring the filtrate until a suspension results;

(c8) adjusting the pH of the suspension to a pH ranging from about 8.5 to about 9; and

(c9) stirring the suspension.

13 . The method of claim 12 , wherein all of sub-steps (c1) to (c9) are conducted at the temperature achieved by the heating of su-step (c1).

14 . The method of claim 12 , wherein the reaction mixture is heated to a temperature ranging from about 0° C. to about 25° C.

15 . The method of claim 12 , wherein sub-steps (c1) and (c2) are repeated to achieve gradual heating.

16 . The method of claim 12 , wherein the pH of the filtrate is adjusted to a pH ranging from about 10.3 to about 10.7 in sub-step (c5).

17 . The method of claim 11 further comprising the step of (d) isolating the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

18 . The method of claim 17 , wherein step (d) comprises the sub-steps of:

(d1) filtering the crystallized N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide from step (c); and

(d2) drying the crystallized N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

19 . The method of claim 18 , wherein a filter cake obtained in sub-step (d1) is washed.

20 . A method of making (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt comprising the steps of:

(a) combining 2-methyltryptamine and (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester to form an admixture;

(b) stirring the admixture for a time and at a temperature sufficient to form an imine intermediate; and

(c) reducing the imine intermediate to form the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

21 . The method of claim 20 , wherein the temperature of step (a) ranges from about 20° C. to about 25° C.

22 . The method of claim 20 , wherein the 2-methyltryptamine and the (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester are dissolved in methanol in step (a).

23 . The method of claim 20 , wherein the admixture is stirred for about 1 hour at a temperature ranging from about 20 to about 25° C.

24 . The method of claim 20 , wherein step (c) comprises the sub-steps of:

(c1) cooling the admixture;

(c2) adding sodium borohydride to the admixture; and

(c3) combining the admixture with hydrochloric acid to precipitate the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

25 . The method of claim 24 , wherein the admixture is diluted with solvent prior to sub-step (c1).

26 . The method of claim 24 , wherein the admixture is cooled to a temperature of about −15° C. in sub-step (c1).

27 . The method of claim 24 , wherein the sodium borohydride in sub-step (c2) is added in portions.

28 . The method of claim 24 , wherein the sodium borohydride in sub-step (c2) is added over about 1 hour while the temperature is maintained at a range from about −15° C. to about −10° C.

29 . The method of claim 24 , wherein the sodium borohydride is added in solid form.

30 . The method of claim 24 , wherein sub-step (c3) is carried out after a period of stirring the admixture of sub-step (c2).

31 . The method of claim 24 , wherein sub-step (c3) is performed by slow addition of the admixture to pre-cooled hydrochloric acid.

32 . The method of claim 31 , wherein the hydrochloric acid is cooled to a temperature of about 0° C. to about 5° C.

33 . The method of claim 24 , wherein sub-step (c3) comprises the su steps of:

(c3a) heating the admixture of sub-step (c2);

(c3b) adding water to the admixture; and

(c3c) adding hydrochloric acid to the admixture to precipitate (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

34 . The method of claim 33 , wherein the admixture is heated to a temperature ranging from about 20° C. to about 25° C. over a period of time of about 25 minutes in sub-step (c3a).

35 . The method of claim 33 , wherein water is added slowly after a period of stirring the admixture of sub-step (c3a).

36 . The method of claim 33 , wherein the hydrochloric acid is added in portions.

37 . The method of claim 34 , wherein the hydrochloric acid is added over a period of time of about 1.5 hours.

38 . The method of claim 35 , wherein a first portion of hydrochloric acid is added over about 1 hour and a second portion of hydrochloric acid is added over about 30 minutes.

39 . The method of claim 20 further comprising the step of (d) crystallizing the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

40 . The method of claim 39 , wherein step (d) comprises the sub-steps of:

(d1) heating the suspension formed when the imine intermediate is reduced in step (c);

(d2) stirring the suspension at the temperature of sub-step (d1);

(d3) cooling the suspension; and

(d4) stirring the suspension at the temperature of sub-step (d3).

41 . The method of claim 40 , wherein the temperature of sub-step (d1) ranges from about 60° C. to about 65° C.

42 . The method of claim 40 , wherein the temperature of sub-step (d3) ranges from about −15° C. to about −10° C.

43 . The method of claim 40 , wherein sub-steps (d1) through (d4) are repeated one or more times.

44 . The method of claim 40 further comprising the step of (e) isolating (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

45 . The method of claim 40 , wherein step (e) comprises the sub-steps of:

(e1) filtering the suspension of step (d); and

(e2) drying the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

46 . The method of claim 45 , wherein a filter cake obtained in sub-step (e1) is washed.

47 . A method of making 2-methyltryptamine comprising the steps of:

(a) providing an admixture of phenylhydrazine and 5-chloro-2-pentanone in ethanol at a first temperature;

(b) adding ethanol to the admixture and refluxing the mixture;

(c) distilling ethanol;

(d) adding water to the residual solution; and

(e) cooling the residual solution to form 2-methyltryptamine.

48 . The method of claim 47 , wherein step (a) comprises the sub-steps:

(a1) providing a solution of phenylhydrazine in ethanol;

(a2) warming the solution to a temperature ranging from about 30° C. to about 40° C.;

(a3) holding the reaction at a temperature ranging from about 35° C. to about 45° C., while 5-chloro-2-pentanone is added to the reaction mixture; and

(a4) holding the reaction for a period of about 30 minutes at the temperature of step (a3).

49 . The method of claim 47 , wherein the reaction mixture is immediately warmed to reflux and held for 50 minutes.

50 . The method of claim 47 , wherein the reaction mixture is cooled to room temperature over a period of about 20 minutes prior to step (c).

51 . The method of claim 47 , wherein ethanol is partially distilled.

52 . The method of claim 47 , wherein distillation is continued and additional water is added to the residual mixture prior to step (e).

53 . The method of claim 47 , wherein the residual solution is cooled to a temperature of less than about 25° C.

54 . The method of claim 47 further comprising the step of:

(f) isolating and purifying the 2-methyltryptamine.

55 . The method of claim 54 , wherein step (f) comprises the sub-steps of:

(f1) washing the residual solution with toluene;

(f2) isolating the 2-methyltryptamine;

(f3) washing the 2-methyltryptamine with toluene; and

(f4) drying the 2-methyltryptamine.

56 . The method of claim 55 , wherein cold toluene is used in step (i).

57 . The method of claim 55 , wherein drying is accomplished under vacuum at 45° C. until a loss on drying of <1% is obtained.

58 . A method of making (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt comprising the steps of:

(a) combining 2-methyltryptamine and (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester to form an admixture;

(b) stirring the admixture for a time and at a temperature sufficient to form an imine intermediate;

(c) reducing the imine intermediate; and

(d) seeding to form the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

59 . The method of claim 58 , wherein the temperature of step (a) ranges from about 20° C. to about 25° C.

60 . The method of claim 58 , wherein the 2-methyltryptamine and the (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester are dissolved in methanol in step (a).

61 . The method of claim 58 , wherein the admixture in step (b) is stirred for about 30 minutes at a temperature ranging from about 20 to about 25° C.

62 . The method of claim 58 , wherein step (c) comprises the sub-steps of:

(c1) cooling the admixture;

(c2) adding sodium borohydride to the admixture; and

(c3) combining the admixture with hydrochloric acid.

63 . The method of claim 58 , wherein the admixture is diluted with solvent prior to sub-step (c1).

64 . The method of claim 62 , wherein the admixture is cooled to a temperature of about −15° C. in sub-step (c1).

65 . The method of claim 62 , wherein the sodium borohydride in sub-step (c2) is added in portions.

66 . The method of claim 62 , wherein the sodium borohydride in sub-step (c2) is added over about 1 hour while the temperature is maintained at a range from about −15° C. to about −10° C.

67 . The method of claim 62 , wherein the sodium borohydride is added in solid form.

68 . The method of claim 62 , wherein sub-step (c3) is performed by slow addition of the admixture to pre-cooled hydrochloric acid.

69 . The method of claim 68 , wherein the hydrochloric acid is cooled to a temperature of about 0° C. to about 5° C.

70 . The method of claim 69 , wherein sub-step (c3) comprises the sub-steps of:

(c3a) heating the admixture of sub-step (c2);

(c3b) adding water to the admixture; and

(c3c) adding hydrochloric acid to the admixture.

71 . The method of claim 70 , wherein the admixture is heated to a temperature ranging from about 20° C. to about 25° C. over a period of time of about 25 minutes in sub-step (c3a).

72 . The method of claim 70 , wherein water is added slowly after a period of stirring the admixture of sub-step (c3a).

73 . The method of claim 70 , wherein the hydrochloric acid is added in portions.

74 . The method of claim 58 , wherein step (d) comprises the sub-steps of:

(d1) heating the suspension formed when the imine intermediate is reduced in step (c);

(d2) stirring the suspension at the temperature of sub-step (d1);

(d3) cooling the suspension; and

(d4) stirring the suspension at the temperature of sub-step (d3).

75 . The method of claim 74 , wherein the temperature of sub-step (d1) is about 65° C.

76 . The method of claim 74 , wherein the temperature of sub-step (d3) ranges from about −15° C. to about −10° C.

77 . The method of claim 71 , wherein sub-steps (d1) through (d4) are repeated one or more times.

78 . The method of claim 71 further comprising the step of (e) isolating (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt.

Assignments (4)
RELEASE OF IP SECURITY INTEREST AT REEL/FRAME 048510/0364 Recorded Oct 31, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SECURA BIO, INC.
Reel/Frame 061814/0821 →
CONFIRMATORY ASSIGNMENT Recorded May 21, 2019
From: NOVARTIS AG
To: SECURA BIO, INC.
Reel/Frame 049246/0720 →
SECURITY INTEREST Recorded Mar 5, 2019
From: SECURA BIO, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048510/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: NOVARTIS PHARMA AG
To: SECURA BIO, INC.
Reel/Frame 048477/0661 →